Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and ...

The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's therapy for patients with a type of ...

The FDA approved taletrectinib (Ibtrozi)-- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment ...

Lung Fibrosis is a progressive, life-limiting condition that causes scarring of the lungs, making breathing increasingly ...

The Ion robot from Intuitive is billed as offering a minimally invasive procedure for biopsies that can help with early ...

Compared with chemotherapy alone, neoadjuvant nivolumab plus chemotherapy extends overall survival in patients with resectable non-small cell lung cancer.

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of ...

This weekend is graduation at Stanford. The keynote for Saturday’s medical school ceremony is a Stanford doctor, professor and now patient. Dr. Bryant Lin is fighting stage four lung cancer.

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...